Robert Ferris
Overview
Explore the profile of Robert Ferris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nikitina A, Kiriy D, Tyshevich A, Tychinin D, Antysheva Z, Sobol A, et al.
Viruses
. 2025 Jan;
17(1).
PMID: 39861794
Human papillomavirus (HPV)-associated head and neck squamous cell carcinoma (HPV-positive HNSCC) has distinct biological characteristics from HPV-negative HNSCC. Using an AI-based analytical platform on meta cohorts, we profiled expression patterns...
2.
Tang A, Dang S, Lao I, Pandya S, Solari M, Maxwell J, et al.
Am J Otolaryngol
. 2024 Aug;
45(6):104451.
PMID: 39137698
Objective: Malnutrition is an important risk factor for patient surgical outcomes. This is especially true for head and neck cancer (HNC) patients receiving a total laryngectomy with free flap reconstruction...
3.
Rao A, Zhang X, Cillo A, Sussman J, Sandlesh P, Tarbay A, et al.
bioRxiv
. 2024 Apr;
PMID: 38645178
Diffuse gliomas are epigenetically dysregulated, immunologically cold, and fatal tumors characterized by mutations in isocitrate dehydrogenase (IDH). Although IDH mutations yield a uniquely immunosuppressive tumor microenvironment, the regulatory mechanisms that...
4.
Melachuri M, Kurukulasuriya C, Rumde P, Patel T, Awad D, Kim S, et al.
Oral Oncol
. 2024 Feb;
151:106703.
PMID: 38422830
Background: Guidelines recommend treatment package time < 85 days and time from surgery to radiation initiation < 6 weeks in head and neck cancer patients. However, HPV positive primaries treated...
5.
Peterson M, Briceno-Robaugh R, OConnor S, Date A, Moonan P, Fukunaga R, et al.
AIDS
. 2023 Sep;
37(13):2103-2104.
PMID: 37755430
No abstract available.
6.
Gupta R, Bal M, Bishop J, Hunter K, Magliocca K, Seethala R, et al.
Head Neck Pathol
. 2023 Jul;
17(3):877-880.
PMID: 37486534
No abstract available.
7.
Goldstein D, Salvatore M, Ferris R, Phelps B, Minior T
Lancet Glob Health
. 2023 Jun;
11(7):e1120-e1124.
PMID: 37349037
Ending the HIV epidemic relies in part on integrating stand-alone HIV programming with primary health-care platforms to improve population-level health and ensure sustainability. Integration of HIV and primary health care...
8.
Dang S, Patel T, Lao I, Sridharan S, Solari M, Kim S, et al.
Laryngoscope
. 2023 Mar;
133(11):2977-2983.
PMID: 36896866
Objectives: Head and neck cancer patients that require major reconstruction often have advanced-stage disease. Discharge disposition of patients can vary and impact time to adjuvant treatment. We sought to examine...
9.
Wildsmith S, Li W, Wu S, Stewart R, Morsli N, Raja R, et al.
Clin Cancer Res
. 2023 Feb;
29(11):2066-2074.
PMID: 36806911
Purpose: Biomarkers that predict response to immune checkpoint inhibitors (ICI) in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) are needed. This retrospective study assessed tumor mutational...
10.
Chen X, Chen L, Kurten C, Jabbari F, Vujanovic L, Ding Y, et al.
PLoS Comput Biol
. 2022 Dec;
18(12):e1010761.
PMID: 36548438
Cells within a tumor microenvironment (TME) dynamically communicate and influence each other's cellular states through an intercellular communication network (ICN). In cancers, intercellular communications underlie immune evasion mechanisms of individual...